您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[港股财报]:欧康维视生物-B二零二三年中期报告 - 发现报告

欧康维视生物-B二零二三年中期报告

2023-09-26港股财报棋***
欧康维视生物-B二零二三年中期报告

(Incorporated in the Cayman Islands with limited liability)( 於開曼群島註冊成立的有限公司 )Stock code股份代號:1477 2023 INTERIM REPORT中期報告 Virtus et Lumen勇 氣 和 光 明 2 4 5 6610 18 32 33 34 35 36 38 61 1526 Ye LIU Lian Yong CHENWei LI •8835 Vistra (Cayman) LimitedP.O. Box 31119 Grand PavilionHibiscus Way802 West Bay RoadGrand Cayman KY1-1205Cayman Islands Ye LIUHKFCGFCG 1858 Lian Yong CHEN 33191901 HKFCGFCG Tricor Services (Cayman Islands) LimitedSecond Floor, Century YardCricket Square, P.O. Box 902Grand Cayman, KY1-1103Cayman Islands 1831717121716 1477 www.ocumension.com (1) 25III 103.7202263090.1%60.5%®®®®®73.1202263025.8%125.9202263063.8%2023COVID-19 OT-10010.24%NDACDENMPAOT-1010.01%IIICDEOT-101-S0.01%0.05%III5IIIIII OT-1010.01% OT-101(0.01%)20232170III 20236OT-101678III III OT-101-S0.01%0.05% 20237OT-101-S0.01%0.05%CDEIIIOT-101OT-101-S OT-101-S OT-1001ZERVIATE®0.24% 20234OT-1001NDAOT-1001ZYRTEC®OT-1001NDAOT-1001 OT-702 OT-702III20233 III OT-502DEXYCU® OT-502III 2023NDA OT-202 20232IOT-202II20232IOT-202 2023II 103.7202263090.1%9,3611,426210 ®46% ®0.2536 20232212607601607®® ® ®® ®2023 1)2)3)®4)®®®®®5) 202263054.52023630103.7(i)(ii)®® (i)202263028.2198.4%202363084.2(ii)20226308.6202363018.2202263017.720236301.0® 202263020.2202363041.0 202263034.382.8%202363062.7 202363014.4202263015.20.8 2023630(i)2.6202263011.7(ii)1.220226300.3 (i)(ii)(iii)2023630114.7202263078.736.0(i)(ii)COVID-19 73.1202263098.425.8%(i)(ii) (i)(ii)(iii) 202363099.6202263075.424.2(i)(ii) 20236300.120226300.40.32022 2023630208.42022630192.715.7(i)(ii)2022 3090 2023630 (i)(ii)(iii)(i)YUTIQ®®®®(ii)®®(iii)®2023630537.0202212311,170.0 202363020221231 202363035.92022123149.0 202363020221231 202363023.92022123126.0 100%2023630 EyePoint20201215.7121.8EyePoint3,010,72220211EyePoint16.6%EyePointEyePoint 2023630EyePoint189.32022123173.420236306.3%2023630 2023630 20236304172023630170.62022630193.72023630 ESOPRSU20212021ESOPRSU20212021 2023630XVXV78352 (1)(i)22,155,605(ii)ESOP21,425,710(iii)RSURSU11,150,050(iv)202110,828,000(v)202110,553,625 (2)(i)3,554,637(ii)RSURSU135,369(iii)2021287,000(iv)2021249,500(3)2023630690,711,280 2023630352 2023630XV23336 (1)6Dimensions Capital GP,LLC6Dimensions Capital6Dimensions Affiliates6Dimensions Capital6 Dimensions Affiliates(2)Lian Yong CHEN(i)(ii)(iii)(3)Boyu Capital Fund IV,L.P.Summer Iris LimitedBoyu Capital General Partner IV, Ltd.BoyuCapital Fund IV,L.P.Boyu Capital Group Holdings Ltd.Boyu Capital General Partner IV, Ltd.Summer Iris Limited78,214,230(4)Boyu Capital Opportunities Master FundBoyu Capital Investment Management LimitedBoyu Capital Group Holdings Ltd.Boyu Capital Group Holdings Ltd.Boyu Capital Opportunities Master Fund3,415,500(5)TLSBeta Pte.Ltd.TemasekLife Sciences Private LimitedTemasekLife Sciences Private LimitedFullertonManagement Pte LtdFullerton Management Pte LtdTemasek Holdings (Private)LimitedTemasek Life Sciences Private LimitedFullerton Management Pte LtdTemasek Holdings (Private)LimitedTLS BetaPte. Ltd.54,169,400(6)Temasek Holdings(Private)LimitedAranda Investments Pte. Ltd.5,277,000Temasek Holdings(Private)Limited(7)CapitalResearch and Management CompanyTheCapital Group Companies,Inc.The CapitalGroup Companies, Inc.Capital Research and Management Company47,735,966(8)2023630690,711,280 2023630XV23336 2023630 (ESOP) ESOP2018523ESOPESOPESOP2022 ESOP 2023630ESOP 2023630ESOP RSU RSU2020428RSURSURSU2022 RSURSU 2023630RSURSU (1)6020%12(2)6020%1216(3)RSU8.15(4)RSU8.03(5)RSU424,020RSURSU2023630RSURSU23,166,9201,102,769RSU(6) 2023630RSU 2021 2021831202120212021202120218112022 2021 20236302021 (1)202172Liu(a)25%(b)25%(c)25%(d)25% 202299Liu(a)25%(b)25%Liu(c)25%Liu(d)25%Liu Liu (2)2021930202299(a)10%(b)20%(c)30%(d)40% 2021930 (3)2021(2) (4) 20236302021 2021 2021202172202120218112022 2021 20236302021 (1)202172Liu(a)25%(b)25%(c)25%(d)25% 202299Liu(a)25%(b)25%Liu(c)25%Liu(d)25%Liu (2)2021930(a)10%(b)20%(c)30%(d)40% 202299(a)10%(b)20%(c)30%(d)40%CMC (3)20212021930202299(2)2021930202299(4)Liu9.92(5)9.92(6)9.79(7)(8)2021691,124 20236302021 RSU (1)2022112553,424,0007.95%5002023630RSU202363040,858,728 (2)202211255,342,0000.795%500202363020236305,342,000 17.07(3) 2023630 20236302022630 2020710 2023630 2023630 20207101,646.4120209112023630 2023630 2021128,000,00028.35202112227.92834.4 781.720211222023630 2023630 2023630 2022 1.LianYong CHEN2019823團20236122487 13.51B(1) 2023630 13.2013.2113.22 2023630•2410 20236302023630 Lian Yong CHEN 33602023630343434 2410 34 2023824 1. 3416 2. 202363020221231 202311 1720211261781212 2. 12 2022123112 (i)202211 (ii)202211 6,114,0006,114,000 3. 3090 3. 3045 60 CDMO FFSCDMOFFSFFS 5. 16.5% 25% 6. 7. 202320226302023630 8. Coral Incentivization LimitedRSU 8. 20232022630RSU 9. 4,194,00013,170,000202263047,135,000 12935,000202263032,182,000954,000202263031,760,000 35,897,0002022123149,036,000 10. 1 2 0 , 8 4 6 , 0 0